HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 9, 5973-5981, March 3, 2006

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 281/9/5973    most recent M511464200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhao, Y. Articles by Stout, C. D. Search for Related Content PubMed PubMed Citation Articles by Zhao, Y. Articles by Stout, C. D. Social Bookmarking                      What's this?

Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole

INSIGHT INTO P450 CONFORMATIONAL PLASTICITY AND MEMBRANE INTERACTION^*

Yonghong Zhao¹, Mark A. White², B. K. Muralidhara, Ling Sun, James R. Halpert, and C. David Stout^¶

From the Department of Pharmacology and Toxicology and the Sealy Center for Structural Biology, University of Texas Medical Branch, Galveston, Texas 77555 and the ^¶Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037

To better understand ligand-induced structural transitions in cytochrome P450 2B4, protein-ligand interactions were investigated using a bulky inhibitor. Bifonazole, a broad spectrum antifungal agent, inhibits monooxygenase activity and induces a type II binding spectrum in 2B4dH(H226Y), a modified enzyme previously crystallized in the presence of 4-(4-chlorophenyl)imidazole (CPI). Isothermal titration calorimetry and tryptophan fluorescence quenching indicate no significant burial of protein apolar surface nor altered accessibility of Trp-121 upon bifonazole binding, in contrast to recent results with CPI. A 2.3 Å crystal structure of 2B4-bifonazole reveals a novel open conformation with ligand bound in the active site, which is significantly different from either the U-shaped cleft of ligand-free 2B4 or the small active site pocket of 2B4-CPI. The O-shaped active site cleft of 2B4-bifonazole is widely open in the middle but narrow at the top. A bifonazole molecule occupies the bottom of the active site cleft, where helix I is bent 15° to accommodate the bulky ligand. The structure also defines unanticipated interactions between helix C residues and bifonazole, suggesting an important role of helix C in azole recognition by mammalian P450s. Comparison of the ligand-free 2B4 structure, the 2B4-CPI structure, and the 2B4-bifonazole structure identifies structurally plastic regions that undergo correlated conformational changes in response to ligand binding. The most plastic regions are putative membrane-binding motifs involved in substrate access or substrate binding. The results allow us to model the membrane-associated state of P450 and provide insight into how lipophilic substrates access the buried active site.

Received for publication, October 21, 2005 , and in revised form, December 12, 2005.

The atomic coordinates and structure factors (code 2BDM) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

^* This work was supported in part by National Institutes of Health Grants ES03619 (to J. R. H.) and GM61545 (to C. D. S.) and NIEHS Center Grant ES06676 (to J. R. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains Figs. S1 and S2.

² Supported by Sealy and Smith Foundation for Medical Research.

¹ To whom correspondence should be addressed. Tel.: 409-772-9670; Fax: 409-772-9642; E-mail: yozhao{at}utmb.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L.-H. Xu, S. Fushinobu, H. Ikeda, T. Wakagi, and H. Shoun Crystal Structures of Cytochrome P450 105P1 from Streptomyces avermitilis: Conformational Flexibility and Histidine Ligation State J. Bacteriol., February 15, 2009; 191(4): 1211 - 1219. [Abstract] [Full Text] [PDF]

				N. Oezguen, S. Kumar, A. Hindupur, W. Braun, B. K. Muralidhara, and J. R. Halpert Identification and Analysis of Conserved Sequence Motifs in Cytochrome P450 Family 2: FUNCTIONAL AND STRUCTURAL ROLE OF A MOTIF 187RFDYKD192 IN CYP2B ENZYMES J. Biol. Chem., August 1, 2008; 283(31): 21808 - 21816. [Abstract] [Full Text] [PDF]

				T.-A. Nguyen, M. Tychopoulos, F. Bichat, C. Zimmermann, J.-P. Flinois, M. Diry, E. Ahlberg, M. Delaforge, L. Corcos, P. Beaune, et al. Improvement of Cyclophosphamide Activation by CYP2B6 Mutants: From in Silico to ex Vivo Mol. Pharmacol., April 1, 2008; 73(4): 1122 - 1133. [Abstract] [Full Text] [PDF]

				S. Kumar, Y. Zhao, L. Sun, S. S. Negi, J. R. Halpert, and B. K. Muralidhara Rational Engineering of Human Cytochrome P450 2B6 for Enhanced Expression and Stability: Importance of a Leu264->Phe Substitution Mol. Pharmacol., November 1, 2007; 72(5): 1191 - 1199. [Abstract] [Full Text] [PDF]

				M. Shebley and P. F. Hollenberg Mutation of a Single Residue (K262R) in P450 2B6 Leads to Loss of Mechanism-Based Inactivation by Phencyclidine Drug Metab. Dispos., August 1, 2007; 35(8): 1365 - 1371. [Abstract] [Full Text] [PDF]

				H. E. Seward, A. Roujeinikova, K. J. McLean, A. W. Munro, and D. Leys Crystal Structure of the Mycobacterium tuberculosis P450 CYP121-Fluconazole Complex Reveals New Azole Drug-P450 Binding Mode J. Biol. Chem., December 22, 2006; 281(51): 39437 - 39443. [Abstract] [Full Text] [PDF]

				C. W. Locuson and T. S. Tracy Identification of Binding Sites of Non-I-Helix Water Molecules in Mammalian Cytochromes P450 Drug Metab. Dispos., December 1, 2006; 34(12): 1954 - 1957. [Abstract] [Full Text] [PDF]

				S. Kumar, L. Sun, H. Liu, B.K. Muralidhara, and J. R. Halpert Engineering mammalian cytochrome P450 2B1 by directed evolution for enhanced catalytic tolerance to temperature and dimethyl sulfoxide Protein Eng. Des. Sel., December 1, 2006; 19(12): 547 - 554. [Abstract] [Full Text] [PDF]

				M. Ekroos and T. Sjogren From the Cover: Structural basis for ligand promiscuity in cytochrome P450 3A4 PNAS, September 12, 2006; 103(37): 13682 - 13687. [Abstract] [Full Text] [PDF]

				B. K. Muralidhara, S. Negi, C. C. Chin, W. Braun, and J. R. Halpert Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains: SOLUTION THERMODYNAMICS AND MOLECULAR MODELING J. Biol. Chem., March 24, 2006; 281(12): 8051 - 8061. [Abstract] [Full Text] [PDF]